Background: Agonist stimulation induces different intracellular trafficking of endothelin receptors (ET A/B R) after internalization. The mechanism is unclear. Results: Stimulation induces ubiquitination, lysosomal targeting, and decreased cell surface ET B R levels. Non-ubiquitinated ET A R and ET B R mutant recycled to plasma membrane with smaller changes in the levels. Conclusion: Ubiquitination determines intracellular trafficking of endothelin receptors. Significance: ET B R ubiquitination fine tunes cellular responses to agonist by regulating cellular receptor levels. . 2 The abbreviations used are: ET-1, endothelin-1; ET A R, endothelin type A receptor; ET B R, endothelin type B receptor; C-tail, C-terminal tail; GPCR, G protein-coupled receptor; fura-2/AM, fura-2/acetoxymethyl ester; HEK293T, human embryonic kidney 293T; HPASMC, human pulmonary artery smooth muscle cells; Myc-Ub, Myc-tagged ubiquitin; ␤ 2 AR, ␤ 2 -adrenergic receptor; CHX, cycloheximide; DN-dynamin, FLAG-tagged dominant negative mutant of rat dynamin; ETR, endothelin receptor.
Two types of G protein-coupled receptors for endothelin-1 (ET-1), ET type A receptor (ET A R) and ET B R, closely resemble each other, but upon ET-1 stimulation, they follow totally different intracellular trafficking pathways; ET A R is recycled back
to plasma membrane, whereas ET B R is targeted to lysosome for degradation. However, the mechanisms for such different fates are unknown. Here we demonstrated that ET B R but not ET A R was ubiquitinated on the cell surface following ET-1 stimulation and that ET B R was internalized and degraded in lysosome more rapidly than ET A R. The mutant ET B R (designated "5KR mutant") in which 5 lysine residues in the C-tail were substituted to arginine was not ubiquitinated, and its rates of internalization and degradation after ET-1 stimulation became slower, being comparable with those of ET A R. Confocal microscopic study showed that following ET-1 stimulation, ET A R and 5KR mutant of ET B R were co-localized mainly with Rab11, a marker of recycling endosome, whereas ET B R was co-localized with Rab7, a marker of late endosome/lysosome. In the 5KR mutant, ET-1-induced ERK phosphorylation and an increase in the intracellular Ca 2؉ concentration upon repetitive ET-1 stimulation were larger. A series of ET B R mutants (designated "4KR mutant"), in which either one of 5 arginine residues of the 5KR mutant was reverted to lysine, were normally ubiquitinated, internalized, and degraded, with ERK phosphorylation being normalized. These results demonstrate that agonist-induced ubiquitination at either lysine residue in the C-tail of ET B R but not ET A R switches intracellular trafficking from recycling to plasma membrane to targeting to lysosome, causing decreases in the cell surface level of ET B R and intracellular signaling.
Endothelin-1 (ET-1) 2 is a vasoconstricting peptide of 21 amino acids, which is synthesized and released in endothelial cells (1) . ET-1 is considered to play an important role in the physiological control of blood pressure and cardiac function and also in the genesis and development of cardiovascular diseases, such as atherosclerosis (2) , cardiac remodeling accompanying chronic heart failure (3) , and pulmonary arterial hypertension (4) . There are two types of receptors for ET-1: endothelin type A receptor (ET A R) and ET B R, both of which are G protein-coupled receptors (GPCRs) (5, 6) . ET A R is coupled with G q and G s (7, 8) , whereas ET B R is coupled with G q and G i (7, 9) . Typically, ET A R is present on vascular smooth muscle cells, and upon agonist stimulation, it induces contraction of the cells to cause vasoconstriction. On the other hand, ET B R is present on vascular endothelial cells, and upon agonist stimulation, it induces nitric oxide production through activation of endothelial nitric-oxide synthase to cause vascular relaxation (10) . ET B R is also known to function as a clearance receptor for ET-1, which removes ET-1 from the extracellular fluid by binding ET-1 and rapidly internalizing into the inside of the cell (11, 12) .
Administration of a receptor agonist ET-1 to whole animals is reported to induce a transient decrease in blood pressure resulting from vasodilatation via ET B R, followed by a long lasting increase in blood pressure resulting from vasoconstriction via ET A R. The biphasic change in blood pressure is considered to result from rapid desensitization of ET B R-mediated response and negligible desensitization of ET A R-mediated response (1, 12, 13) .
The different susceptibility to desensitization of ET A R-and ET B R-mediated responses could be explained mainly by differ-ent intracellular trafficking of both receptors after stimulation with their agonist ET-1 (14, 15) , although ET A R and ET B R closely resemble each other (ϳ55% overall; 77% within the putative transmembrane helices) (16, 17) . Upon agonist stimulation, both receptor subtypes are rapidly internalized to early endosome but subsequently targeted to different intracellular destinations (14, 18) . ET A R is recycled back to the plasma membrane through the pericentriolar recycling compartment, whereas ET B R is targeted to lysosomes for degradation through late endosome (14, 18) .
Several lines of evidence indicate that the cytoplasmic C-tail determines the pathway of agonist-induced trafficking of several GPCRs, including endothelin receptors (ETRs) (19, 20) . With respect to ETRs, this conclusion is based on the studies using chimeric mutants of ETRs where the C-tails of ET A R and ET B R were swapped (15, 21) . The chimeric ET B R with the C-tail of ET A R was capable of recycling like wild type ET A R, whereas the chimeric ET A R with the C-tail of ET B R behaved like wild type ET B R (15, 21) . However, the detailed mechanism for the different fates of ET A R and ET B R is at present totally unknown.
We have recently shown that ET B R is ubiquitinated more abundantly than ET A R in the absence of agonist stimulation (22) . To gain insights into the mechanisms for different fates of these two receptors, we decided to examine agonist-induced ubiquitination of ET A R and ET B R and to analyze the role of ubiquitination in receptor trafficking.
In this study, we show that 1) the different fates of ET A R and ET B R are mainly due to agonist-induced ubiquitination of ET B R but not ET A R, which occurs on the cell membrane; 2) ubiquitination of ET B R switches intracellular trafficking of the receptor after agonist-induced internalization, from recycling back to the plasma membrane to lysosomal targeting for degradation, causing a decrease in cell surface levels of the receptor; 3) ubiquitination of the receptor and the consequent decrease in its cell surface levels induce quenching of ET B Rmediated responses, such as ERK phosphorylation, and an increase in the intracellular Ca 2ϩ concentration ([Ca 2ϩ ] i ) to repetitive agonist stimulation; and 4) ubiquitination at any one of 5 lysine residues with the exception of lysine 411 in the distal end of the C-tail of ET B R is sufficient for a switch of the intracellular trafficking.
EXPERIMENTAL PROCEDURES
Reagents and Antibodies-The following reagents and antibodies were used: synthetic human ET-1 (Peptide Institute); probenecid (Sigma-Aldrich); fura-2/acetoxymethyl ester (fura-2/AM) and pluronic F-127 (Dojindo Laboratories); cycloheximide and N-ethylmaleimide (Calbiochem); EZ-Link TM Sulfo-NHS-SS-Biotin and streptavidin-agarose resin (Thermo Fisher Scientific); siGENOME SMARTpool ␤-arrestin-1 (M-011971-01), siGENOME SMARTpool ␤-arrestin-2 (M-007292-00) and siGENOME control pool Non-Target-ing#1 (D-001206-13-05) (Thermo Scientific Dharmacon); mouse monoclonal anti-HA epitope tag antibody and Alxa488conjugated mouse monoclonal anti-HA antibody (Covance); rabbit polyclonal anti-Myc epitope tag antibody (Millipore); rabbit polyclonal anti-phospho-ERK1/2 (Thr-202/Tyr-204) antibody, rabbit polyclonal anti-ERK1/2 antibody and normal rabbit IgG (Cell Signaling Technology); mouse monoclonal anti-GAPDH antibody, mouse monoclonal anti-ubiquitin antibody (P4D1), and mouse monoclonal ␤-arrestin-2 antibody (H-9) (Santa Cruz Biotechnology, Inc.); rabbit monoclonal anti-␤-arrestin-1 antibody and rabbit monoclonal anti-endothelin B receptor (anti-ET B R) antibody (Abcam); and goat polyclonal anti-mouse IgG conjugated to HRP, goat polyclonal anti-rabbit IgG conjugated to HRP, and light chain-specific mouse monoclonal anti-rabbit IgG conjugated to HRP (Jackson Immuno-Research Laboratories).
Cell Culture and Transfection-Human embryonic kidney 293T (HEK293T) cells were grown in DMEM supplemented with 10% FBS, 100 units/ml penicillin, and 100 g/ml streptomycin at 37°C in a humidified atmosphere containing 5% CO 2 . Human pulmonary artery smooth muscle cells (HPASMC) were grown in DMEM supplemented with 20% FBS, 100 units/ml penicillin, and 100 g/ml streptomycin at 37°C in a humidified atmosphere containing 5% CO 2 . For transfection of plasmid and/or siRNA, Lipofectamine 2000 reagent (Invitrogen) was used according to the manufacturer's instructions.
Generation of Stable Cell Lines-HEK293T cells stably expressing wild type or mutant N-terminally HA-tagged ETRs, and HEK293T cells stably expressing Myc-ubiquitin were generated by retroviral gene transfer as described previously (23, 24) . The positive cells were selected in DMEM containing 2 g/ml puromycin for a week, and individual lines were tested by Western blot using an anti-HA antibody. Mutagenesis was performed using the KOD-Plus-Mutagenesis kit (Toyobo) according to the manufacturer's instructions. All of the constructs were verified by DNA sequencing.
Western Blot-The proteins were separated by SDS-PAGE and electrotransferred to a polyvinylidene fluoride membrane (Millipore) with an electroblotter. After transfer, the membranes were washed three times with TBST (10 mM Tris-HCl (pH 8.0), 100 mM NaCl, and 0.1% Tween 20) followed by blocking (2% nonfat dry milk in TBST) of nonspecific binding for 1 h at room temperature. The membranes were incubated with specific antibodies as a primary antibody at 4°C overnight. The primary antibody was detected with a secondary antibody conjugated with HRP. The protein-antibody complex was detected by enhanced chemiluminescence Western blot reagent (Thermo Fisher Scientific). The membranes were exposed to Amersham Biosciences Hyperfilm TM ECL (GE Healthcare), and the signals were quantified with ImageJ version 1.37 software (National Institutes of Health).
Ubiquitination Assay-The HEK293T cells stably expressing wild type or mutant HA-ETRs were transiently transfected with expression vector encoding Myc-tagged ubiquitin (Myc-Ub). Two days after transfection, the cells were incubated with or without ET-1 (30 nM) and lysed using lysis buffer (150 mM NaCl, 1.5 mM MgCl 2 , 50 mM Tris-HCl (pH 6.8), 1% Nonidet P-40, 0.5% sodium deoxycholate, 0.1% SDS, 1 mM PMSF, 1 mM Na 3 VO 4 , 20 mM NaF, 10 g/ml leupeptin, 10 g/ml aprotinin, and 10 g/ml pepstatin) containing 20 mM N-ethylmaleimide to inhibit deubiquitinating enzymes. The cell lysates were centrifuged at 20,000 ϫ g for 20 min at 4°C. Anti-HA antibody (mouse monoclonal) and protein G-Sepharose (GE Healthcare) were added to the supernatants, and the mixture was incubated with rotation at 4°C overnight. The immunocomplexes were washed four times with washing buffer, 1% Nonidet P-40, 0.5% sodium deoxycholate, 0.1% SDS) and then analyzed for ubiquitination of receptors by Western blot using rabbit polyclonal anti-Myc antibody and goat polyclonal anti-rabbit IgG antibody conjugated to HRP as primary and secondary antibodies, respectively. Reprobing for immunoprecipitated HA-ETRs was performed using anti-HA antibody and goat polyclonal antimouse IgG antibody conjugated to HRP as primary and secondary antibodies.
The ubiquitination assay for endogenous ET B R in HPASMC was performed in a manner essentially similar to that for exogenously expressed HA-ET B R in HEK293T cells, except for the following points. For immunoprecipitation of ET B R, rabbit monoclonal anti-ET B R antibody instead of anti-HA antibody was added to the supernatants of cell lysates, whereas Western blot analysis of ubiquitinated ET B R was performed using mouse monoclonal anti-ubiquitin antibody and goat polyclonal anti-mouse IgG antibody conjugated to HRP as primary and secondary antibodies, respectively. Reprobing for immunoprecipitated endogenous ET B R was performed using rabbit monoclonal anti-ET B R antibody and light chain-specific mouse monoclonal anti-rabbit IgG antibody conjugated to HRP as primary and secondary antibodies, respectively.
Cell Surface HA-ETR Assay-The cells (2 ϫ 10 6 ) expressing wild type or mutant HA-ETRs were incubated with 30 nM ET-1 for the indicated times at 37°C. After washing three times with ice-cold PBS (pH 7.4) and resuspension in PBS, the cells were incubated with rotation with 0.5 mg/ml EZ-Link TM Sulfo-NHS-SS-Biotin at 4°C for 1 h to biotinylate cell surface proteins, and the reaction was quenched by adding 50 mM Tris-HCl (pH 8.0) plus PBS, followed by two washes with ice-cold PBS. The cells were lysed with lysis buffer and centrifuged at 20,000 ϫ g for 20 min at 4°C. The supernatants were incubated with streptavidin-agarose resin at 4°C for 1.5 h to collect biotinylated proteins. The precipitates were washed four times with washing buffer, and biotinylated proteins on the streptavidinagarose resin were eluted by adding SDS sample buffer (62.5 mM Tris-HCl (pH 6.8), 10% glycerol, 5% 2-mercaptoethanol, 2.5% SDS, 0.1% bromphenol blue). The resulting supernatant was subjected to Western blot analysis to detect HA-ETRs, which had been on the cell surface after ET-1 stimulation.
Analysis of Intracellular Trafficking by Confocal Microscopy-To determine intracellular trafficking pathways for ETRs, we analyzed co-localization of ETRs with either Rab7 or Rab11 as a marker for late endosome/lysosome or recycling endosome, respectively. For this purpose, HEK293T cells were plated on a collagen-coated 35-mm diameter glass base dish (Iwaki, Japan) at a density of 3 ϫ 10 5 cells/dish. The cells were transiently transfected with either of the expression vectors for C-terminally GFP-tagged WT ET A R (ET A R-GFP), ET B R WT-GFP, and ET B R 5KR-GFP, along with either C-terminally tdTomatotagged Rab7 (Rab7-tdTomato) or Rab11-tdTomato. Twentyfour hours after transfection, the cells were incubated with or without ET-1 for 30 min and fixed in 4% paraformaldehyde for 15 min at room temperature. Images were captured by confocal laser microscopy (FV10i, Olympus) and analyzed quantitatively using MetaMorph software (Universal Imaging, West Chester, PA). Namely, vesicles positive for GFP signal or tdTomato signal within each cell were defined based on their intensity and diameter, and subsequently, the number of vesicles within each cell that showed signals for either GFP, tdTomato, or both was counted. The extent of co-localization of receptors with Rab proteins was represented as a percentage of the number of vesicles showing both signals to the total number of vesicles showing GFP signal alone. Results were obtained from three independent experiments, with 10 -13 cells being analyzed in each experiment.
Analysis of Internalization of ETRs by Confocal Microscopy-HA-ET B R-expressing cells were washed and incubated with Alexa488-conjugated anti-HA antibody for 1 h at 4°C in serum-free DMEM. After washing twice with PBS, the cells were incubated with vehicle or 30 nM ET-1 for 30 min at 37°C, washed with PBS, and fixed with 4% paraformaldehyde. Images were captured by confocal laser microscopy (FV10i, Olympus). Using MetaMorph software, measurements were made in single cells by selecting a region encompassing the entire plasma membrane (defined as the total cell region) and then selecting a region just inside the plasma membrane (1.6 m inside the total cell region, defined as the cell inside region). The difference between these two regions was defined as the cell membrane region. Fluorescence intensity in the total cell region and cell inside region was measured, and fluorescence intensity in the cell membrane region was calculated based on fluorescence intensity in these two regions. For estimation of the amount of the internalized receptors, the ratio of the fluorescence intensity in the cell membrane region to that in the total cell region was determined.
Measurement of the Intracellular Ca 2ϩ Concentration ([Ca 2ϩ ] i )-[Ca 2ϩ
] i was measured as described previously (25, 26) . HEK293T cells expressing wild type or mutant HA-ET B Rs were incubated in culture medium containing with 4 M fura-2/AM, 2.5 mM probenecid, and 0.04% pluronic F-127 at 37°C for 60 min under reduced light. After washing, the cells were suspended in Ca 2ϩ -free Krebs-HEPES solution (140 mM NaCl, 3 mM KCl, 1 mM MgCl 2 , 11 mM D-(ϩ)-glucose, 10 mM HEPES; adjusted to pH 7.3 with NaOH) at 4 ϫ 10 5 cells/ml and stored at 4°C under reduced light. Immediately before [Ca 2ϩ ] i measurement, CaCl 2 was added to a 0.5-ml aliquot of the cell suspension at a final concentration of 2 mM. [Ca 2ϩ ] i was measured at 30°C using a CAF-110 spectrophotometer (JASCO) with excitation wavelengths of 340 and 380 nm and an emission wavelength of 500 nm. Data were collected and analyzed using MacLab/8s and Chart (version 3.5) software (ADInstruments, Nagoya, Japan).
Data Analysis-All data were presented as mean Ϯ S.E. The significance of the difference between mean values was evaluated with GraphPad PRISM TM (version 3.00, GraphPad Software Inc.) by Student's unpaired t test. A p value less than 0.05 was considered to indicate statistically significant differences.
RESULTS

ET B R but Not ET A R Is Ubiquitinated in C-tail in Response to
ET-1 Stimulation-To evaluate possible ubiquitin modification of the ETRs, we generated HEK293T cells stably expressing either N-terminally HA-tagged ET A R or ET B R (referred to as HA-ET A R or HA-ET B R, respectively). The cells were tran- DECEMBER 19, 2014 • VOLUME 289 • NUMBER 51 JOURNAL OF BIOLOGICAL CHEMISTRY 35285 siently transfected with expression vector encoding Myc-Ub, stimulated with ET-1 for the indicated times, and lysed. HA-ET A R or HA-ET B R was immunoprecipitated, and the extent of receptor ubiquitination was determined by Western blot (Fig.  1A ). Before stimulation with ET-1 (at 0 min), a broad band larger than 80 kDa representing the ubiquitinated receptor was observed for HA-ET B R, but essentially no signal was observed for HA-ET A R. After stimulation with 30 nM ET-1, no detectable ubiquitination of HA-ET A R was observed. In sharp contrast, ubiquitination of HA-ET B R was augmented within 5 min after ET-1 stimulation and lasted for at least 20 min ( Fig. 1, A and B) .
Endothelin A and B Receptor Ubiquitination and Trafficking
To confirm the relevance of our findings for exogenously expressed receptors in HEK293T cells, we investigated ET-1induced ubiquitination of endogenously expressed ET B R in HPASMC and obtained essentially similar results ( Fig. 1 , C and D). ␤-Arrestins have been shown to function as adaptors for ubiquitination of GPCRs, such as ␤ 2 -adrenergic receptor (␤ 2 AR) (27, 28) , whereas both ETRs are known to recruit ␤-arrestins (18, 21) . Therefore, we examined a role of ␤-arrestins in ubiquitination of ET B R. Knockdown of ␤-arrestin 1 and ␤-arrestin 2 was without effect on basal and ET-1-induced ubiquiti-nation of ET B R, demonstrating that ␤-arrestins play no significant role in ubiquitination of ET B R (Fig. 2) .
In order to determine the role of ubiquitination in the regulation of ET B R trafficking, we constructed mutant ET B R, which would not be ubiquitinated. ET B R has 16 lysine residues in the cytoplasmic region: 8 lysine residues in C-tail ( Fig. 3A ) and 8 other lysine residues in the cytoplasmic loops. Because recent studies have indicated that the C-tail might be a major site of ubiquitination in GPCRs (29 -32), we first replaced 8 lysine residues in the C-tail with arginine (designated HA-ET B R 8KR). In contrast with wild type HA-ET B R, the mutant receptor was found to be not ubiquitinated in an agonist-dependent manner ( Fig. 3B ), suggesting that lysine residues in C-tail are major sites of ubiquitination in ET B R.
Previously, we demonstrated that ET B R is palmitoylated at the cysteine cluster of the C-tail and anchored to the plasma membrane ( Fig. 3A) (9) , generating a small loop structure between the seventh transmembrane domain and the palmitoylation sites (Fig. 3A) . The amino acid sequences of the loop structure are very similar between ET A R and ET B R (84% identical) (15), whereas the sequence homology of the region distal to palmitoylation sites is relatively low (26% identical), suggest- ing the possibility that lysine residues in the region distal to palmitoylation sites in the C-tail of ET B R are the targets for ubiquitination. Therefore, we generated another ET B R mutant in which 5 lysine residues (Lys-411, Lys-417, Lys-422, Lys-424, and Lys-438) distal to the palmitoylation sites in the C-tail were replaced with arginine (designated HA-ET B R 5KR). As shown in Fig. 3C , HA-ET B R 5KR was not ubiquitinated in an agonistdependent manner, suggesting that lysine residues distal to the palmitoylation sites are major targets for ubiquitination of ET B R.
Receptor Ubiquitination Is Involved in ET-1-induced ET B R Internalization-To gain insights into the functional significance of ETR ubiquitination, receptor internalization was examined using the biotin-streptavidin system to measure the amount of cell surface receptor. The level of cell surface HA-ET B R rapidly decreased following ET-1 stimulation with a halflife of about 15 min (Fig. 4, A and B) . The level of cell surface HA-ET A R decreased similarly with HA-ET B R up to 10 min, but thereafter, it remained almost unchanged (Fig. 4, A and B) . Notably, HA-ET B R 5KR, the mutant that was not ubiquitinated, disappeared from the cell surface at a rate similar to that of HA-ET B R WT up to 10 min but thereafter at a far slower rate ( Fig. 4, C and D) ; the time course of disappearance was similar to that of HA-ET A R (Fig. 4, B and D) .
Next, we attempted to confirm slower internalization of HA-ET B R 5KR in comparison with that of HA-ET B R WT using confocal microscopy. Before stimulation with ET-1, the major part of HA-ET B R WT and HA-ET B R 5KR was present on the cell membrane ( Fig. 5 , A (top panels) and B (left)). Thirty minutes after stimulation with ET-1, most of both receptors were internalized, and the number of the receptors remaining on the cell membrane became smaller. Quantitative analysis showed that before ET-1 stimulation, the ratio of cell membrane fluorescence intensity to total cell fluorescence intensity was comparable between cells expressing HA-ET B R WT and HA-ET B R 5KR but that after a 30-min stimulation with ET-1, it was twice as large in cells expressing HA-ET B R 5KR as in cells expressing HA-ET B R WT ( Fig. 5, A (bottom panels) and B (right)).
Receptor Ubiquitination Is Involved in ET-1-induced ET B R Degradation-We next investigated the role of ubiquitination in ET-1-induced receptor degradation. For this purpose, we determined the disappearance rate of total ETRs in the whole cells after ET-1 stimulation in the presence of a protein synthesis inhibitor, cycloheximide (CHX). In the presence of CHX, the level of total HA-ET B R decreased with time after ET-1 stimulation, whereas that of total HA-ET A R was almost unchanged, at least, for 30 min (Fig. 6, A and B) . The disappearance rate of non-ubiquitinated HA-ET B R 5KR was slower than HA-ET B R WT (Fig. 6, C and D) and comparable with that of HA-ET A R (Fig. 6, B and D) . These results suggest that receptor ubiquitination accelerates ET B R degradation.
Time Course for Recovery of Cell Surface Levels of HA-ET B R WT and HA-ET B R 5KR following ET-1 Stimulation-In an effort to gain further understanding of the cellular dynamics of HA-ET B R and HA-ET B R 5KR, we examined the time course for recovery of cell surface levels of these receptors following ET-1 stimulation. For this purpose, after a 30-min stimulation with ET-1, the cells stably expressing HA-ET B R WT and HA-ET B R 5KR were washed two times with ET-1-free medium, cultured for the indicated times and lysed for quantification of cell surface levels of HA-ET B R WT and HA-ET B R 5KR by a biotinylation assay. After a 30-min stimulation with ET-1, cell surface levels of HA-ET B R WT and HA-ET B R 5KR were reduced to ϳ30 and 70%, respectively, of control values before stimulation, remained constant up to 2 h, and thereafter began to increase; the level of HA-ET B R 5KR was recovered to the control level around 4 h, whereas recovery for the level of HA-ET B R WT was not complete even 8 h after stimulation (Fig. 7) .
ET B R Is Ubiquitinated on the Cell Membrane-We asked whether the ET-1-induced ET B R ubiquitination occurs before or after internalization. For that purpose, we overexpressed a FLAG-tagged dominant negative mutant of rat dynamin (DNdynamin) to inhibit ET B R internalization (21) and examined its effect on ET B R ubiquitination. In control cells transfected with empty vector alone, cell surface HA-ET B R rapidly decreased following ET-1 stimulation (Fig. 8A, top) . In contrast, in cells transfected with DN-dynamin, the disappearance rate of cell surface HA-ET B R became markedly slower (Fig. 8A, top) , indicating that internalization of cell surface HA-ET B R was inhibited by DN-dynamin. Notably, inhibition of internalization by DN-dynamin did not affect ET B R ubiquitination induced by ET-1 stimulation (Fig. 8, B and C) , indicating that ET B R is ubiquitinated before internalization, probably on the cell membrane. DECEMBER 19, 2014 • VOLUME 289 • NUMBER 51
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Confocal Microscopic Study of Intracellular Trafficking of ET A R, ET B R, or ET B R 5KR-The apparent rate of receptor internalization in the present study reflects the sum of the rate of receptor endocytosis and the rate of receptor recycling to plasma membrane. Therefore, the slower disappearance of HA-ET B R 5KR from the cell surface following ET-1 stimulation could result from either a decrease in the rate of the receptor endocytosis process itself or an increase in receptor recycling to the plasma membrane. To differentiate these two possibilities, we analyzed intracellular trafficking pathways of HA-ET A R, HA-ET B R WT, and HA-ET B R 5KR using confocal microscopy. For this purpose, we examined co-localization of these receptors with Rab7, a marker for late endosome/lysosome, and Rab11, a marker for recycling endosome (33, 34) . In one series of experiments, ET A R-GFP, ET B R-GFP, or ET B R 5KR-GFP was transiently transfected into HEK293T cells along with Rab7-tdTomato ( Fig. 9, A and C) , whereas in the other series, either one of the receptors was transiently transfected with Rab11-tdTomato ( Fig. 9, B and D) . In the absence of ET-1, most of these receptors were localized to the plasma membrane. After a 
30-min stimulation with ET-1, most of the ET A R-GFP, ET B R-GFP, and ET B R 5KR-GFP was internalized to the intracellular vesicular structures. ET A R-GFP was rarely co-localized with
Rab7-tdTomato, whereas ET B R WT-GFP was frequently co-localized with Rab7-tdTomato ( Fig. 9, A and C) . Notably, ET B R 5KR-GFP showed rare co-localization with Rab7-tdTomato, like ET A R-GFP ( Fig. 9, A and C) . Conversely, ET A R-GFP and ET B R 5KR-GFP were frequently co-localized with Rab11-tdTomato ( Fig. 9, B and D) , whereas ET B R WT-GFP was rarely co-localized with it ( Fig. 9, B and D) . These data clearly demonstrate that after agonist stimulation, ET A R and non-ubiquitinated ET B R mutant (5KR) are mainly on the recycling pathway, whereas ET B R is mainly targeted to the lysosome for degradation and, hence, that the slower rate of apparent internalization for ET B R 5KR at the later phase after ET-1 stimulation is mainly due to recycling to the plasma membrane of the receptor.
Functional Significance of ET B R Ubiquitination in Cellular Signaling-To clarify how receptor ubiquitination affects ET B R-mediated intracellular signaling, we examined ERK phosphorylation and an increase in [Ca 2ϩ ] i in cells stably expressing HA-ET B R WT or HA-ET B R 5KR in response to two successive stimulations with ET-1. For this purpose, the cells were first stimulated for 30 min with 30 nM ET-1, and they were washed two times with culture medium to remove ET-1; after incubation in fresh medium for 15 min for equilibration, the cells were again stimulated with 30 nM ET-1. In response to the first stimulation, ERK phosphorylation levels were increased in cells expressing HA-ET B R WT or HA-ET B R 5KR, and the increases were comparable with each other (Fig. 10, A and B) . Notably, ERK phosphorylation levels in response to the second stimulation became smaller compared with the first responses in both types of cells, but the levels were 2-3 times larger in cells expressing HA-ET B R 5KR than those in cells expressing HA-ET B R WT (Fig. 10, A and B) . The increase in [Ca 2ϩ ] i induced by the first ET-1 stimulation in HA-ET B R 5KR-expressing cells was similar to that in HA-ET B R WT-expressing cells (Fig. 10C,  left panel) , but the increase by the second stimulation was about 60% larger than that in HA-ET B R WT-expressing cells (Fig.  10C, right) . Taking into consideration that the second stimulation was given during the time when changes in cell surface levels of HA-ET B R WT and HA-ET B R 5KR following the first stimulation are maintained at about 30 and 70% of the values before the first stimulation, respectively, these results strongly demonstrate that larger responses to the second stimulation for HA-ET B R 5KR are due mainly to higher levels of cell surface HA-ET B R 5KR following the first stimulation, resulting from a switch of intracellular trafficking from lysosomal targeting to recycling to the plasma membrane. However, considering that ERK phosphorylation and an increase in [Ca 2ϩ ] i induced by the second ET-1 stimulation are significantly smaller than the responses expected from cell surface levels of the receptors, it is likely that desensitization mechanisms other than reduced levels of receptors are involved in the reduced responses to the second ET-1 stimulation.
Ubiquitination of Either One Lysine Residue Is Sufficient for ET-1-induced ET B R Internalization-
We asked which lysine residue(s) in the C-tail was responsible for ET-1-induced ubiquitination and lysosomal targeting of ET B R. To clarify this point, we generated a series of ET B R mutants in which any one of 5 arginine residues (Arg-411, Arg-417, Arg-422, Arg-424, and Arg-438) in the C-tail of HA-ET B R 5KR was reverted to the original lysine (referred to as HA-ET B R 4KR-411K, -417K, -422K, -424K, or -438K, respectively) and examined the ET-1induced ubiquitination of these mutants. In response to ET-1 stimulation, all of these mutant ET B Rs were ubiquitinated to a level comparable with that of HA-ET B R WT (Fig. 11, A and B) , suggesting that any one of the 5 lysine residues in the C-tail of ET B R WT can be a site of ubiquitination and also that ET B R WT is ubiquitinated at only one lysine residue.
We next examined ET-1-induced internalization of these HA-ET B R 4KR mutants. The disappearance rate of all of these mutants except for HA-ET B R 4KR-411K from the cell surface was recovered to that of HA-ET B R WT; the disappearance rate of HA-ET B R 4KR-411K remained low and was similar to that of non-ubiquitinated mutant HA-ET B R 5KR (Fig. 11C) . We wondered whether the dissociation between ubiquitination and internalization of HA-ET B R 4KR-411K could be due to a difference in assay conditions (i.e. the absence or presence of overexpression of Myc-Ub). Therefore, internalization of the receptor was analyzed after overexpression of Myc-Ub. Overexpression of Myc-Ub did not affect the disappearance rate of HA-ET B R 4KR-411K from the cell surface compared with the rate in the absence of overexpression of Myc-Ub (data not shown). These data suggest that ubiquitination of any one lysine residue in the C-tail except for lysine 411 is sufficient for ET-1-induced ET B R internalization.
We also examined the ET-1-induced degradation rates of HA-ET B R 4KR mutants, which were indexed by the ET-1-induced decrease in whole cell levels of wild type or mutant HA-ET B Rs for 30 min after treatment with CHX, a protein synthesis inhibitor. As described in the legend to Fig. 6, B and D, in the presence of CHX, ET-1 stimulation for 30 min decreased the whole cell level of wild type HA-ET B R to 65% of the control value without the stimulation, whereas it had little effect on the DECEMBER 19, 2014 • VOLUME 289 • NUMBER 51 whole cell level of non-ubiquitinated mutant HA-ET B R 5KR (Fig. 11D) . In response to ET-1, the whole cell levels of all HA-ET B R 4KR mutants except for 4KR-411K decreased to an extent comparable with those of wild type HA-ET B R, whereas the level of HA-ET B R 4KR-411K was virtually unchanged (Fig. 11D) . Overexpression of Myc-Ub did not affect the ET-1-induced degradation rate of HA-ET B R 4KR-411K (data not shown).
Endothelin A and B Receptor Ubiquitination and Trafficking
These results indicate that ubiquitination of any one of the 5 lysine residues except for lysine 411 in the C-tail of ET B R is sufficient for ET-1-induced ET B R degradation.
Finally, we examined ERK phosphorylation in cells stably expressing HA-ET B R 4KR in response to two successive stimulations with ET-1. An increase in ERK phosphorylation in response to the first stimulation was similar between HA-ET B R WT and HA-ET B R 4KR mutant ( Fig. 12A ) (data not shown). In accordance with the recovery of receptor internalization and degradation rates, ERK phosphorylation response to the second stimulation was recovered in cells expressing any one of the HA-ET B R 4KR mutants except for HA-ET B R 4KR-411K to the level in cells expressing HA-ET B R WT (Fig. 12B ) (data not shown), whereas the response in cells expressing HA-ET B R 4KR-411K remained larger than that in cells expressing HA-ET B R WT.
DISCUSSION
Two types of receptors for ET-1, ET A R and ET B R, closely resemble each other, but after stimulation with their agonist, they are well known to follow totally different intracellular trafficking pathways (14, 15) . In other words, after agonistinduced endocytosis, ET A R is mainly recycled back to the plasma membrane, whereas ET B R is targeted to the lysosome for degradation (14, 18) . In the present study, we have dem- After stimulation, the cells were washed with ET-1-free medium and cultured for the indicated times. Cell surface receptor levels were analyzed by the biotinylation method as described in the legend to Fig.  4 . Shown are representative blots from three independent experiments. B, cell surface receptor levels were quantified and normalized to total receptor levels in cell lysates, which were quantified by Western blot analysis, and the value after normalization at each time is represented as a percentage of the value before stimulation (the values at Ϫ0.5 h). Each point represents the mean Ϯ S.E.M. of three independent experiments. ##, p Ͻ 0.01 versus the value at Ϫ0.5 h for HA-ET B R WT; *, p Ͻ 0.05; **, p Ͻ 0.01 versus the value at Ϫ0.5 h for HA-ET B R 5KR. onstrated that 1) the different fates of ET A R and ET B R are mainly due to agonist-induced ubiquitination of ET B R but not ET A R, which occurs on the cell membrane; 2) ubiquitination of ET B R switches intracellular trafficking of the receptor after agonist-induced internalization from recycling back to the plasma membrane to targeting to lysosome for degradation, causing a decrease in cell surface levels of the receptor; 3) ubiquitination of the receptor and the consequent decrease in its cell surface levels induce quenching of ET B R-mediated responses, such as ERK phosphorylation, and an increase in [Ca 2ϩ ] i to repetitive agonist stimulation; and 4) ubiquitination at any one of the 5 lysine residues except for lysine 411 in the distal end of the C-tail of ET B R is sufficient for a switch of the intracellular trafficking.
ET B R, but not ET A R, expressed endogenously in cell lines (HPASMC) and exogenously in HEK293T cells, was specifically ubiquitinated in an agonist-dependent manner, although both receptors possessed several lysine residues as potential ubiquitination sites. Wild type ET B R has a total of 16 lysine residues in the cytoplasmic region as potential ubiquitination sites: 8 lysine residues in the cytoplasmic loops and 8 lysine residues in the C-tail. In the C-tail, 3 lysine residues are present between the seventh transmembrane domain and palmitoylation sites, whereas 5 lysine residues are present between the palmitoylation sites and C-tail end (distal C-tail) (Fig. 3A) . Using mutant receptors named HA-ET B R 8KR and HA-ET B R 5KR (in which lysine residues in the whole C-tail and distal C-tail were replaced with arginine, respectively), it was clearly shown that among these 16 potential ubiquitination sites of ET B R, it is the 5 lysine residues in distal C-tail that are critical for agonistinduced ubiquitination of ET B R. Conversely, using another series of mutant receptors named ET B R 4KR, in which any one of 5 arginine residues in HA-ET B R 5KR was reverted to the original lysine, it was shown that wild type ET B R was ubiquitinated at any one of 5 lysine residues in its C-tail and that any single lysine residue in the distal C-tail of ET B R except for lysine 411 can function as a ubiquitination site. However, it is unknown whether a preferable ubiquitination site is present and, if present, which lysine residue is the most preferable for ubiquitination. Furthermore, the ubiquitination of ET B R was found to occur on the cell membrane, according to the experiments with dominant negative dynamin. This result is consistent with the previous report on the -opioid receptor (35) . The reason for lack of ET A R ubiquitination is at present unknown, although ET A R has 3 lysine residues as potential ubiquitination sites in the distal C-tail. This difference could be due to the fact that that ET A R is not a good substrate for any E3 ligase.
It is well known that ␤-arrestins function as adaptors for ubiquitination of GPCRs, such as the ␤ 2 AR (27, 28) , and also that both ET A R and ET B R recruit ␤-arrestins upon agonist stimulation (18, 21) . However, it is unlikely that ␤-arrestins are involved in ubiquitination of ET B R, based on the finding that knockdown of both ␤-arrestin-1 and ␤-arrestin-2 has little effect on ET-1-induced ubiquitination of the receptor. These results demonstrate that E3 ligase for ET B R may not require adaptor proteins for its recruitment to the receptor or that it may use adaptor proteins other than ␤-arrestins.
Ubiquitination of ET B R switches intracellular trafficking of the receptor after agonist-induced endocytosis from recycling back to the plasma membrane to targeting to lysosome for degradation, causing a decrease in cell surface levels of ET B R. In other words, ubiquitinated ET B R WT was targeted to the lysosome for degradation, judging from the ET-1-induced decrease in the total amount of the receptor following protein synthesis inhibition by CHX and by dominant localization of ET B R WT to late endosomes/lysosomes following ET-1 stimulation. In contrast, non-ubiquitinated ET B R mutant (ET B R 5KR) was found to be recycled back to the plasma membrane, as evidenced by the negligible ET-1-induced decrease in the total amount of the receptor following protein synthesis inhibition and by dominant localization of the receptor to recycling endosomes following ET-1 stimulation. This pattern of intracellular trafficking for non-ubiquitinated ET B R mutant is similar to that for ET A R, which is not ubiquitinated. Furthermore, restoration It is reported that some membrane proteins, including ␤ 2 AR and low density lipoprotein receptor-related protein, are recycled to the plasma membrane by trans-acting proteins, such as SNX27 (sorting nexin 27) and SNX17, respectively, which interact with the C-tail of those membrane proteins (36, 37) . Therefore, it is possible that such trans-acting proteins are involved in recycling of ET A R and probably ET B R 5KR, which shows the same receptor kinetics as ET A R. In the case of wild type ET B R, the lysosomal targeting signal by receptor ubiquitination might overwhelm the recycling signal by trans-acting proteins, or ubiquitination of ET B R might simply inhibit the binding of trans-acting proteins to the receptor. The previous report that a C-tail-truncated mutant of ET A R is neither internalized nor recycled to the plasma membrane (15, 21) may support the presence of such trans-acting proteins. Such transacting proteins of ET A R and ET B R remain to be identified.
The present study clearly shows that ubiquitination at any one of 5 lysine residues in the distal C-tail of ET B R except for lysine 411 is sufficient for switching intracellular trafficking of ET B R from recycling to plasma membrane to lysosomal target-ing. However, the reason why intracellular trafficking of HA-ET B R 4KR-411K is not recovered despite its ability to be ubiquitinated is at present unknown. It may be because ubiquitination of HA-ET B R 4KR at Lys-411 is not an effective signal either for lysosomal targeting or for inhibiting the binding of recycling machinery, such as the above mentioned transacting proteins, to the receptor.
The present finding that ubiquitination promotes degradation of ET B R is consistent with previous reports for ␤ 2 AR, CXCR4, vasopressin V2 receptor, protease-activated receptor 2, neurokinin-1 receptor, -opioid receptor, and ␦-opioid receptor (28 -31, 38 -40) . On the other hand, there are few reports showing the involvement of ubiquitination in apparent receptor internalization (or the rate of disappearance of cell surface receptors). In other words, in the case of ␤ 2 AR, CXCR4, vasopressin V2 receptor, -opioid receptor, and ␦-opioid receptor, ubiquitination has little effect on the rate of apparent receptor internalization, whereas it accelerates internalization of the -opioid receptor without effect on receptor recycling to the plasma membrane. In this context, ubiquitination of ET B R is unique in that it accelerates the apparent receptor internalization by switching intracellular trafficking from recycling to lysosomal targeting, presumably without effect on the internal- DECEMBER 19, 2014 • VOLUME 289 • NUMBER 51 JOURNAL OF BIOLOGICAL CHEMISTRY 35293 ization process itself. However, it remains to be determined whether ubiquitination of ET B R directly affects the internalization process itself. The reason for different roles of ubiquitination in receptor internalization among ET B R, the -opioid receptor, and the other GPCRs is at present unknown, but it might depend on the difference of E3 ligases being involved and the consequent properties/sites of ubiquitination. Indeed, a recent study on ␤ 2 AR demonstrates that following binding of different ligands (one is isoprenaline (␤AR agonist), whereas the other is carvedilol (␤AR antagonist)) to the receptor, different E3 ligases (such as Nedd4 and MARCH2, respectively) are recruited to ubiquitinate different sites of the receptor, causing different regulation of receptor trafficking (i.e. ubiquitination of ␤ 2 AR by Nedd4 accelerates only lysosomal targeting of the receptor, whereas that by MARCH2 accelerates both receptor internalization and lysosomal targeting) (41) .
Endothelin A and B Receptor Ubiquitination and Trafficking
Regarding the functional significance of agonist-induced ubiquitination of ET B R, the present study demonstrates that a decrease in the cell surface levels of ET B R, resulting from agonist-induced acceleration of degradation of ubiquitinated ET B R, is mainly responsible for quenching of ET B R-mediated intracellular responses, such as ERK phosphorylation and an increase in [Ca 2ϩ ] i to repetitive agonist stimulation. However, considering that ERK phosphorylation and [Ca 2ϩ ] i response induced by the second ET-1 stimulation are significantly smaller than the responses expected from the extent of a decrease in cell surface levels of the receptors, it is likely that receptor desensitization as well as reduced levels of receptors are involved in the reduced responses to the second ET-1 stim-ulation. The mechanisms for desensitization remain to be determined.
The ET B R expression level is reported to be elevated in several pathologic conditions, such as atherosclerosis, chronic heart failure, and pulmonary hypertension (42) (43) (44) (45) , and it is probable that the elevated ET B R levels play a critical role in the genesis and/or development of these pathological conditions. In this context, it is important to investigate the molecular mechanism for the elevated receptor levels, especially in terms of disturbed ubiquitination or enhanced deubiquitination in those pathological conditions. Such a study might lead to discovery of a novel mechanism for genesis and/or development of these pathological conditions and also of a novel therapeutic strategy for those pathological conditions.
